Skip to content

Erwin Dreesen

  • MSc, PharmD
  • Catholic University of Leuven
  • 4h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 57CitationsNumber of citations received by Erwin's publications. Updated daily.

Other IDs

Co-authors (29)

Publications (5)

  • Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response

    • Dreesen E
    • Van Stappen T
    • Ballet V
    • et al.
    N/AReaders
    3Citations
    Get full text
  • Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics

    • Murias S
    • Magallares L
    • Albizuri F
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases

    • Dreesen E
    • Bossuyt P
    • Mulleman D
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit from Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling

    • Passot C
    • Pouw M
    • Mulleman D
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Variability in golimumab exposure: A 'real-life' observational study in active ulcerative colitis

    • Detrez I
    • Dreesen E
    • Van Stappen T
    • et al.
    N/AReaders
    18Citations
    Get full text

Education

Katholieke Universiteit Leuven